Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 106

1.

Bioidentical hormone therapy in menopause: relevance in dermatology.

Borda LJ, Wong LL, Tosti A.

Dermatol Online J. 2019 Jan 15;25(1). pii: 13030/qt4c20m28z.

2.

Human versus non-human sex steroid use in hormone replacement therapies part 1: Preclinical data.

Atwood CS, Ekstein SF.

Mol Cell Endocrinol. 2019 Jan 15;480:12-35. doi: 10.1016/j.mce.2018.10.003. Epub 2018 Oct 9. Review.

PMID:
30308266
3.

Establishing a Rationale for Compounding Hormone Replacement Therapy.

Biundo B.

Int J Pharm Compd. 2018 May-Jun;22(3):190-195.

PMID:
29878886
4.

Conjugated equine estrogen and medroxyprogesterone acetate are associated with decreased risk of breast cancer relative to bioidentical hormone therapy and controls.

Zeng Z, Jiang X, Li X, Wells A, Luo Y, Neapolitan R.

PLoS One. 2018 May 16;13(5):e0197064. doi: 10.1371/journal.pone.0197064. eCollection 2018.

5.

Prescribing Bioidentical Menopausal Hormone Therapy: A Survey of Physician Views and Practices.

Dubaut JP, Dong F, Tjaden BL, Grainger DA, Duong J, Tatpati LL.

J Womens Health (Larchmt). 2018 Jul;27(7):859-866. doi: 10.1089/jwh.2017.6637. Epub 2018 Mar 27.

PMID:
29583064
6.

Compounded Bioidentical Hormone Therapy: Does the Regulatory Double Standard Harm Women?

Stuenkel CA, Manson JE.

JAMA Intern Med. 2017 Dec 1;177(12):1719-1720. doi: 10.1001/jamainternmed.2017.5141. Review. No abstract available.

PMID:
29052690
7.

Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making.

Thompson JJ, Ritenbaugh C, Nichter M.

BMC Womens Health. 2017 Oct 2;17(1):97. doi: 10.1186/s12905-017-0449-0.

8.

A comparative characterization of estrogens used in hormone therapy via estrogen receptor (ER)-α and -β.

Perkins MS, Louw-du Toit R, Africander D.

J Steroid Biochem Mol Biol. 2017 Nov;174:27-39. doi: 10.1016/j.jsbmb.2017.07.022. Epub 2017 Jul 22.

PMID:
28743541
9.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON MENOPAUSE-2017 UPDATE.

Cobin RH, Goodman NF; AACE Reproductive Endocrinology Scientific Committee.

Endocr Pract. 2017 Jul;23(7):869-880. doi: 10.4158/EP171828.PS. Erratum in: Endocr Pract. 2017 Dec;23 (12 ):1488.

PMID:
28703650
10.

Promotion and marketing of bioidentical hormone therapy on the internet: a content analysis of websites.

Yuksel N, Treseng L, Malik B, Ogbogu U.

Menopause. 2017 Oct;24(10):1129-1135. doi: 10.1097/GME.0000000000000901.

PMID:
28609391
11.

Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use.

L'Hermite M.

Climacteric. 2017 Jun;20(3):205-211. doi: 10.1080/13697137.2017.1285277. Epub 2017 Feb 9. Review.

PMID:
28509626
13.

Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal.

L'Hermite M.

Climacteric. 2017 Aug;20(4):331-338. doi: 10.1080/13697137.2017.1291607. Epub 2017 Mar 16. Review.

PMID:
28301216
14.

Bioidentical hormone therapy: An assessment of provider knowledge.

Files JA, Kransdorf LN, Ko M, Kling JM, David PS, Pruthi S, Sood R, Creedon D, Chang YH, Mayer AP.

Maturitas. 2016 Dec;94:46-51. doi: 10.1016/j.maturitas.2016.08.014. Epub 2016 Aug 23.

PMID:
27823744
15.

Bioidentical Estrogen for Menopausal Depressive Symptoms: A Systematic Review and Meta-Analysis.

Whedon JM, KizhakkeVeettil A, Rugo NA, Kieffer KA.

J Womens Health (Larchmt). 2017 Jan;26(1):18-28. doi: 10.1089/jwh.2015.5628. Epub 2016 Sep 7. Review.

PMID:
27603786
16.

The impact of micronized progesterone on the endometrium: a systematic review.

Stute P, Neulen J, Wildt L.

Climacteric. 2016 Aug;19(4):316-28. doi: 10.1080/13697137.2016.1187123. Epub 2016 Jun 9. Review.

17.

Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement.

Santoro N, Braunstein GD, Butts CL, Martin KA, McDermott M, Pinkerton JV.

J Clin Endocrinol Metab. 2016 Apr;101(4):1318-43. doi: 10.1210/jc.2016-1271. Review.

PMID:
27032319
18.

Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study.

Velentzis LS, Banks E, Sitas F, Salagame U, Tan EH, Canfell K.

PLoS One. 2016 Mar 23;11(3):e0146494. doi: 10.1371/journal.pone.0146494. eCollection 2016.

19.

Prepubertal Gynecomastia Due to Indirect Exposure to Nonformulary Bioidentical Hormonal Replacement Therapy: A Case Report.

De Pinho JC, Aghajanova L, Herndon CN.

J Reprod Med. 2016 Jan-Feb;61(1-2):73-7.

PMID:
26995893
20.

Bioidentical hormone therapy: a challenge for the menopause clinician.

Richardson MK.

Menopause. 2016 Apr;23(4):353-4. doi: 10.1097/GME.0000000000000629. No abstract available.

PMID:
26908206

Supplemental Content

Loading ...
Support Center